NCT06140537View on ClinicalTrials.gov

Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

October 31, 2028

Study Completion Date

December 31, 2028

Conditions
Kidney Transplant; ComplicationsVascular DiseasesDiabetes
Interventions
DRUG

Dapagliflozin 10mg Tab

Dapagliflozin 10mg orally daily

DRUG

Placebo

Placebo one tablet orally daily

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER